thyroid gland medullary carcinoma (Cancer)
Information
- Disease name
- thyroid gland medullary carcinoma
- Disease ID
- DOID:3973
- Description
- "A thyroid gland carcinoma that has_material_basis_in parafollicular cells." [url:http\://en.wikipedia.org/wiki/Medullary_thyroid_cancer]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02293954 | Active, not recruiting | N/A | Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer | November 11, 2015 | December 30, 2024 |
| NCT02867592 | Active, not recruiting | Phase 2 | Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors | May 18, 2017 | September 21, 2024 |
| NCT00068497 | Completed | N/A | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer | August 2003 | |
| NCT00118248 | Completed | Phase 2 | Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer | December 2004 | April 2012 |
| NCT00134043 | Completed | Phase 2 | Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer | December 2005 | March 2009 |
| NCT00519896 | Completed | Phase 2 | Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer | July 2007 | September 2015 |
| NCT00655655 | Completed | Phase 1 | Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors | December 2004 | January 11, 2018 |
| NCT01155258 | Completed | Phase 1 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | June 2010 | May 2014 |
| NCT01204476 | Completed | Phase 1 | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma | October 2010 | |
| NCT01709435 | Completed | Phase 1 | Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors | November 14, 2012 | December 31, 2019 |
| NCT02592356 | Completed | N/A | Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer | November 16, 2015 | March 1, 2024 |
| NCT00004074 | Completed | Phase 1 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | August 1999 | |
| NCT00028496 | Completed | Phase 1 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | November 2001 | |
| NCT03892993 | Recruiting | N/A | Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers | April 9, 2019 | August 1, 2028 |
| NCT04759911 | Recruiting | Phase 2 | Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer | February 26, 2021 | September 10, 2024 |
- Disase is a (Disease Ontology)
- DOID:3963
- Cross Reference ID (Disease Ontology)
- MESH:C536914
- Cross Reference ID (Disease Ontology)
- NCI:C3879
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:255032005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0238462
- Exact Synonym (Disease Ontology)
- Medullary carcinoma of the Thyroid gland
- Exact Synonym (Disease Ontology)
- medullary thyroid carcinoma
- Exact Synonym (Disease Ontology)
- Ultimobranchial thyroid tumor
- Exact Synonym (Disease Ontology)
- Ultimobranchial thyroid tumour